Low rate of Immunoresponse to the novel split virion, inactivated, adjuvanted pandemic H1N1 influenza vaccine in HIV-1 infected patients

M. Bickel, I. Wieters, N. Von Hentig, P. Khaykin, G. Nisius, A. Haberl, C. Stephan, H.W. Doerr, H.R. Brodt & R. Allwinn
Objective: To determine immunoresponse after single intramuscular dose of the novel split virion, inactivated, adjuvanted pandemic H1N1 influenza vaccine (A/California/7/2009(H1N1)v-like strain (X-179 A) in HIV-1 infected patients. Response rates to this vaccine in the general population[for full text, please go to the a.m. URL]